Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Pediatr. 2000 Dec;12(6):603-9.

Osteogenesis imperfecta: perspectives and opportunities.

Author information

1
Department of Pathology, University of Washington, Seattle 98195-7470, USA. pbyers@u.washington.edu

Abstract

The last 2 years have seen additions proposed to the very limited armamentarium of treatments for osteogenesis imperfecta. These include the use of bisphosphonates to decrease bone resorption, growth hormone to augment growth and collagen production, and bone marrow transplantation to create chimeras at the level of the collagen production unit in bone. Although there are optimistic proponents for each strategy, the lack of well-controlled studies and the absence of clearly defined objectives for therapy hinder clear assessment.

PMID:
11106283
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins - Ovid Insights
    Loading ...
    Support Center